Drug
Fosbretabulin tromethamine clinical trials
A product of Fosbretabulin; its studies count on that page too.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 2
Mateon Therapeutics (4) · National Cancer Institute (NCI) (1) · West Virginia University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Fosbretabulin
- One of Antimitotic Agents source
Studies
Open first, then newest update. How each study uses fosbretabulin tromethamine is read from its arms, and is right about nine times in ten.
Testing it · 6
- FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian CancerTerminatedPhase 2/3Mateon TherapeuticsNCT02641639Written as Fosbretabulin tromethamine
- Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerCompletedPhase 2National Cancer Institute (NCI)NCT01305213Written as Fosbretabulin Tromethamine
- A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated BiomarkersCompletedPhase 2Mateon TherapeuticsNCT02132468Written as fosbretabulin tromethamine
- OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade GliomasWithdrawnPhase 1West Virginia UniversityNCT01052363Written as Bevacizumab, CA4P
- Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid CancerTerminatedPhase 2/3Mateon TherapeuticsNCT00507429Written as CA4P
- Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid TumorsCompletedPhase 1Mateon TherapeuticsNCT00395434Written as Combretastatin A4 Phosphate (CA4P)
Codes
What other systems call fosbretabulin tromethamine · ClinicalTrials.gg INT016658
- UNII (FDA) GBW044919EFOSBRETABULIN TROMETHAMINEConfirmed FDA, Wikidata
- Wikidata Q27279017fosbretabulin tromethamineConfirmed FDA, Wikidata
- NCI Thesaurus C83721Fosbretabulin TromethamineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | GBW044919E | FOSBRETABULIN TROMETHAMINE | Confirmed FDA, Wikidata |
| Wikidata | Q27279017 | fosbretabulin tromethamine | Confirmed FDA, Wikidata |
| NCI Thesaurus | C83721 | Fosbretabulin Tromethamine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.